Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

Detalhes bibliográficos
Main Authors:	Lei, M, Wu, L, Terrar, D, Huang, C
Formato:	Journal article
Idioma:	English
Publicado em:	American Heart Association 2019

Registos relacionados

Letter to the editor regarding the article of Chen et al.
Por: Mehmet Sami Islamoglu, et al.
Publicado em: (2022-12-01)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
Por: Joanne J. A. van Bavel, et al.
Publicado em: (2018-02-01)

Arrhythmia Models for Drug Research: Classification of Antiarrhythmic Drugs
Por: Keitaro Hashimoto
Publicado em: (2007-01-01)

Letter by Antoniades et al regarding article, "Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction".
Por: Antoniades, C, et al.
Publicado em: (2010)

Letter by Rider and Neubauer regarding article, "Cardiac remodeling in obesity".
Por: Rider, O, et al.
Publicado em: (2013)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
Por: T. N. Lipnitsky, et al.
Publicado em: (2007-12-01)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
Por: T. N. Lipnitsky, et al.
Publicado em: (2007-12-01)

Modernised classification of cardiac anti-arrhytmic drugs
Por: Lei, M, et al.
Publicado em: (2018)

Response by Peterzan et al to letter regarding article, “Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction”
Por: Peterzan, MA, et al.
Publicado em: (2020)

Letter to the Editor Regarding Vaping Article
Por: Rabbi Yehuda Spitz
Publicado em: (2019-10-01)

Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs
Por: Sutanto, H, et al.
Publicado em: (2019)

A Letter to the Editor on the Article by Farnam et al
Por: Anne Rutte, MSc, et al.
Publicado em: (2015-06-01)

Interactions that matter: 10 Antiarrhythmic drugs
Por: Aronson, J
Publicado em: (1987)

Letter regarding article by Becker et al, "Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase".
Por: Antoniades, C, et al.
Publicado em: (2005)

Letter to the Editor regarding Cunningham et al. 2020
Publicado em: (2021-04-01)

Effects of Antiarrhythmic Drugs on Apoptotic Pathways in H9c2 Cardiac Cells
Por: Shojiro Isomoto, et al.
Publicado em: (2006-01-01)

A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs
Por: Ahmad Beik, et al.
Publicado em: (2020-05-01)

An algorithm for the selection of antiarrhythmic drugs for clinical pharmacologist
Por: A. A. Upnitskiy
Publicado em: (2014-12-01)

Antiarrhythmic Drug Dosing in Children—Review of the Literature
Por: Nathalie Oeffl, et al.
Publicado em: (2023-05-01)

Letter to the editor—Opinion on article by Rodriguez-Alvarez F et al.
Por: Santiago Rodríguez Villafuerte, et al.
Publicado em: (2025-01-01)

A Letter to the Editor on the Article by Farnam et al.—Author's Response
Por: Farnam Farnaz, PhD, et al.
Publicado em: (2015-09-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
Por: IRAJ NAZERY , et al.
Publicado em: (1986-12-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
Por: IRAJ NAZERY, et al.
Publicado em: (1986-05-01)

Letter to the Editor regarding article Health effects of voluntary exposure to cold water – a continuing subject of debate, by Espeland, et al
Por: Richard A. Reinhart
Publicado em: (2023-12-01)

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
Por: V. L. Doshchitsin, et al.
Publicado em: (2022-07-01)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
Por: B. A. Tatarsky, et al.
Publicado em: (2021-08-01)

Antiarrhythmic Drug Use in Pregnancy: Considerations and Safety Profiles
Por: Marco Valerio Mariani, et al.
Publicado em: (2024-08-01)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
Por: Sean P. Gaine, et al.
Publicado em: (2023-04-01)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
Por: Gheorghe-Andrei Dan, et al.
Publicado em: (2018-12-01)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
Por: Ibrahim El-Battrawy, et al.
Publicado em: (2019-08-01)

Electrophysiological Effects of a New Antiarrhythmic Drug Aksaritmin
Por: Ravshanbek D. Kurbanov, et al.
Publicado em: (2019-06-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
Por: Koichiro Kumagai, MD, et al.
Publicado em: (2011-01-01)

Initiation and outcomes with Class Ic antiarrhythmic drug therapy
Por: Xu Gao, et al.
Publicado em: (2018-03-01)

Letter to the Editor in regard to the “Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome” by Roedl et al.”
Por: A. D. Krieg, et al.
Publicado em: (2021-11-01)

Response to letter by Campbell et al. regarding the results of the COSTICK trial
Por: Andrew Smyth, et al.
Publicado em: (2023-07-01)

Reply letter to “response to article by Johnna Perdrizet et al.” by Gomez and colleagues
Por: Johnna Perdrizet, et al.
Publicado em: (2022-01-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
Por: K. A. Skiba, et al.
Publicado em: (2003-06-01)

A letter to the editor regarding the original article by Costa et al: Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria
Por: Biggs, M
Publicado em: (2019)

Letter to the Editor regarding article “Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID‐19 pneumonia”
Por: Fenglin Jiang
Publicado em: (2021-07-01)

Response by Shimura et al. to the letter regarding article “Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement”
Por: Tetsuro Shimura, et al.
Publicado em: (2021-08-01)